Login
From:
Sleep Review
(Uncensored)
subscribe
Alkermes to Acquire Avadel, Adding LUMRYZ to Its Portfolio
https://sleepreviewmag.com/sleep-disorders/hypersomnias/alkermes-acquire-avadel-adding-lumryz/
links
backlinks
Tagged with:
acquisitions
narcolepsy
emerging compounds
avadel
alkermes
hypersomnias
lumryz
The $2.1 billion all-cash deal will bring Avadel’s once-nightly oxybate, LUMRYZ, under Alkermes’ umbrella as it advances its orexin agonist pipeline for narcolepsy and other hypersomnolence disorders.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
